News Beximco Pharmaceuticals Limited London S.E.

Equities

BXP

US0885792061

Delayed London S.E. Other stock markets 03:54:48 2024-04-25 am EDT			5-day change	1st Jan Change
36.47 ^GBX	-0.08%		-0.08%	-12.12%

Mar. 04	Beximco names Iqbal Ahmed as managing director	AN
Jan. 30	Beximco Pharmaceuticals to strengthen portfolio as interim profit up	AN

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Beximco names Iqbal Ahmed as managing director	Mar. 04	AN
Beximco Pharmaceuticals to strengthen portfolio as interim profit up	Jan. 30	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 30, 2023	Jan. 30	CI
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Jan. 29	CI
Beximco MD steps down to join Bangladeshi cabinet	Jan. 11	AN
Beximco Pharmaceuticals Limited Announces Stepping Down of Mr. Nazmul Hassan as Member of the Board	Jan. 11	CI
Beximco Pharmaceuticals Limited Announces Stepping Down of Mr. Nazmul Hassan as Managing Director	Jan. 11	CI
Ex-dividend day for final dividend	Nov. 13	FA
Beximco Pharmaceuticals Posts Higher Fiscal Q1 Profit, Revenue	Nov. 06	MT
Beximco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 06	CI
Beximco boosts revenue in local currency but profit falls	Nov. 01	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	Nov. 01	CI
Beximco Pharmaceuticals Limited Proposes Dividend for the Year Ended June 30, 2023	23-10-20	CI
Beximco working to fix deficiencies at manufacturing plant	23-09-11	AN
Beximco Pharmaceuticals to Tackle Ophthalmic Manufacturing Unit Deficiencies After Malta Medicines Authority Audit	23-09-11	MT
EARNINGS UPDATES: HC Slingsby profit falls, East Imperial loss narrows	23-05-02	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	23-05-01	CI
TRADING UPDATES: Ferro-Alloy eyes revenue to drop below market view	23-01-30	AN
Beximco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	23-01-30	CI
Beximco Pharmaceuticals Limited Announces Cash Dividend for the Year Ended June 30, 2022	23-01-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Beximco Pharmaceuticals Limited London S.E.

Equities

BXP

US0885792061

Summary

Filters